Anticancer Activity of Cerium Oxide Nanoparticles Towards Human Lung Cancer Cells

Cerium oxide nanoparticles (CeO2 NPs) have gained significant attention in various fields, including biomedicine, semiconductors, cosmetics, and fuel cells, due to their unique physico-chemical properties. Notably, green-synthesized CeO2 NPs have demonstrated enhanced potential as drug carriers, particularly in biomedical applications such as anti-inflammatory, anticancer, antimicrobial, and anti-oxidant therapies. This study aimed to investigate the anticancer effects of cerium oxide nanoparticles synthesized using turmeric rhizomes on human lung cancer cells. The cytotoxicity and proliferation inhibition of these nanoparticles were assessed using MTT and Live/Dead assays, revealing a dose-dependent reduction in cell viability. Additionally, reactive oxygen species (ROS) generation was quantified through ROS assays, confirming oxidative stress induction as a key mechanism of cytotoxicity. Cell proliferation analysis further demonstrated that increasing concentrations of CeO2 NPs significantly reduced the multiplication of healthy lung cancer cells. These findings highlight the potential of turmeric-derived CeO2 NPs as a promising therapeutic agent for lung cancer treatment, warranting further exploration of their mechanism of action and in vivo efficacy.